We highlight recent advances in flow cytometry that have potential app
lications in the pharmaceutical sciences, particularly in pharmacodyna
mics and drug delivery. These advances are discussed in the context of
the preclinical development of anticancer agents, immunosuppressants
and immunomodulators, and oligonucleotides and gene therapy.